Skip to main content
Staff Login
Username
*
Enter your The Contraceptive Pipeline Database username.
Password
*
Enter the password that accompanies your username.
Log in
Forgot password
Toggle navigation
Justicia Gendarussa
Product Overview
Alternative Name:
Gendarussa
Development Status:
Active Development
Target:
Male
Mode:
Non-hormonal
Delivery Type:
Oral
Duration Type:
Short-acting
Description:
The active ingredient in Justicia Gendarussa, a plant grown in Indonesia, disrupts sperm function, preventing the sperm from fertilizing the ovum. The effect is short term and reversible, and has no effect on sperm production or male hormones.
Updated date:
October 20, 2016
Vertical Tabs
Product Details
Active Pharmaceutical Ingredient (API):
Gendarussin
Potential Multi-Purpose Technology (MPT):
No
Regimen:
One pill per day
Partner:
Airlangga University
,
Indopharma
,
FHI 360
Status
Project Phase:
Early Development
Project Stage:
Phase II
Began discovery in:
1985
Status Details:
While Phase 2 studies in Indonesia are complete, they were not GCP-compliant; FDA approvals would have to start at the beginning.
Discussions are ongoing with the Indonesian FDA, the National Agency - Drug and Food Control (NA-DFC) to seek approval in Indonesia.
Programmatic Considerations
Additional Information
Download Product Report
